Silence Therapeutics plc (SLN) a un PER historique négatif de -3.0, ce qui signifie que l'entreprise est actuellement non rentable sur la base des douze derniers mois (TTM). Le rendement bénéficiaire historique est de -33.37%.
Critères prouvés par cette page:
Score Global SharesGrow : 56/100 avec 3/7 critères réussis.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendement du Dividende |
|---|---|---|---|---|---|
| 2016 | -43.5 | -1.85 | 6.78 | 477.31 | - |
| 2017 | -208.0 | 2.50 | 6.43 | 21,031.88 | - |
| 2018 | -19.5 | -0.02 | 10.22 | 0.00 | - |
| 2019 | -18.8 | 3.16 | 17.61 | 1,509.12 | - |
| 2020 | -13.5 | -0.31 | 48.45 | 80.11 | - |
| 2021 | -13.3 | -0.61 | 61.38 | 42.15 | - |
| 2022 | -2.7 | -0.01 | 6.13 | 6.25 | - |
| 2023 | -3.9 | 0.49 | 7.68 | 6.65 | - |
| 2024 | -2.3 | 0.07 | 0.79 | 2.45 | - |
| 2025 | -3.2 | 0.16 | 4.61 | 513.72 | - |
| Year | EPS (Dilué) | Chiffre d'Affaires | Résultat Net | Marge Nette |
|---|---|---|---|---|
| 2016 | $-0.36 | $770K | $-8.44M | -1096.1% |
| 2017 | $-0.07 | $16K | $-1.62M | -10112.5% |
| 2018 | $-0.78 | $0.00 | $-18.41M | - |
| 2019 | $-0.78 | $244K | $-19.58M | -8025.4% |
| 2020 | $-1.20 | $5.48M | $-32.55M | -594% |
| 2021 | $-1.32 | $12.42M | $-39.41M | -317.4% |
| 2022 | $-1.26 | $17.5M | $-40.49M | -231.4% |
| 2023 | $-1.17 | $25.38M | $-43.27M | -170.5% |
| 2024 | $-0.98 | $43.26M | $-45.31M | -104.7% |
| 2025 | $-1.89 | $559K | $-88.61M | -15851.9% |
| Year | EPS (Moy.) | Fourchette EPS | CA (Moy.) | Fourchette CA | Analystes |
|---|---|---|---|---|---|
| 2026 | $-0.54 | $-0.85 – $-0.17 | $4.16M | $56.34K – $13.52M | 3 |
| 2027 | $-0.58 | $-0.77 – $-0.48 | $4.96M | $45.23K – $12.06M | 2 |
| 2028 | $-0.66 | $-2.62 – $0.19 | $14.43M | $182.4K – $47.27M | 1 |
| 2029 | $-0.65 | $-2.57 – $0.18 | $78.8M | $996.37K – $258.19M | 1 |
| 2030 | $-0.56 | $-2.22 – $0.16 | $168.9M | $2.14M – $553.41M | 1 |
